Turchini, Laura
 Distribuzione geografica
Continente #
NA - Nord America 233
EU - Europa 194
AS - Asia 86
AF - Africa 1
Totale 514
Nazione #
US - Stati Uniti d'America 229
IT - Italia 68
SE - Svezia 53
SG - Singapore 42
CN - Cina 18
IE - Irlanda 18
FR - Francia 17
ID - Indonesia 15
DE - Germania 8
GB - Regno Unito 7
KR - Corea 6
CA - Canada 4
ES - Italia 4
FI - Finlandia 4
NL - Olanda 4
IN - India 3
PT - Portogallo 3
BE - Belgio 2
JP - Giappone 2
AT - Austria 1
HR - Croazia 1
MK - Macedonia 1
NG - Nigeria 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 514
Città #
Chandler 63
Singapore 36
Ashburn 34
Rome 23
New York 20
Dublin 16
Jakarta 14
Marseille 14
Boardman 9
Boston 7
Milan 7
Princeton 7
Seoul 6
Los Angeles 5
Beijing 4
Bergamo 3
Chelsea 3
Helsinki 3
Lisbon 3
Munich 3
Seattle 3
Toronto 3
Washington 3
Amsterdam 2
Ancona 2
Arzachena 2
Atlanta 2
Bremen 2
Brussels 2
Cagliari 2
Cattolica 2
Duiven 2
Frankfurt am Main 2
Houston 2
Logroño 2
Monza 2
Oristano 2
Paris 2
Pune 2
Rancho Cucamonga 2
Spring Arbor 2
Tianjin 2
Brescia 1
Busto Arsizio 1
Claremont 1
Dortmund 1
Florence 1
Gdansk 1
Ghaziabad 1
Girona 1
Hackney 1
Harlow 1
Hirakata 1
Hounslow 1
Iesi 1
Lagos 1
Lappeenranta 1
London 1
Massa 1
Mondolfo 1
Montreal 1
Nagoya 1
Newark 1
Pamplona 1
Sacramento 1
San Diego 1
Santa Clara 1
Trieste 1
Vienna 1
Zagreb 1
Totale 355
Nome #
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 64
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy 59
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 53
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre 50
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease 47
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 47
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 46
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 36
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study 36
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 28
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 22
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19 21
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy 13
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 9
Totale 531
Categoria #
all - tutte 3.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202241 0 0 0 0 0 0 0 0 0 9 19 13
2022/2023213 32 25 11 20 21 18 23 11 19 4 8 21
2023/2024195 3 34 16 9 7 33 15 15 10 15 18 20
2024/202582 8 7 32 10 25 0 0 0 0 0 0 0
Totale 531